Description

AGP Limited's exclusive session on Sputnik-V reviewing the preclinical and clinical evidence, immune response, vaccine efficacy and safety to date. 

Subject

Sputnik-V CoViD Vaccine 

Period19 Feb 2021

Media contributions

1

Media contributions